Literature DB >> 19183327

Enhanced recovery programmes and colorectal surgery: does the laparoscope confer additional advantages?

S Khan1, M Gatt, J MacFie.   

Abstract

BACKGROUND: Enhanced recovery after surgery (ERAS) protocols aim to reduce postoperative lengths of stay (LOS). Laparoscopic surgery shares the same objective. Whether or not laparoscopic surgery conveys additional benefits over and above those achievable with ERAS alone is unclear.
METHOD: A review of the literature from January 1966 to June 2008 was performed. Randomized trial and case series investigating the role of laparoscopic surgery within ERAS protocols were included. These were assessed for LOS, readmissions, return of gut function, quality of life and cost of treatment.
RESULTS: Four publications from three randomized trials and another seven case series were identified. Two randomized trials revealed no difference in the LOS and readmission rates between ERAS when used alone and ERAS with the inclusion of laparoscopic surgery. However, a third trial revealed a significantly shorter LOS and a lower readmission rate in the ERAS and laparoscopic group.
CONCLUSION: The limited evidence presently available suggests that no further benefit is obtained by the inclusion of laparoscopic surgery in ERAS protocols. Further research is needed to derive more definitive conclusions.

Mesh:

Year:  2009        PMID: 19183327     DOI: 10.1111/j.1463-1318.2009.01781.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  11 in total

Review 1.  Adoption of enhanced recovery after surgery (ERAS) strategies for colorectal surgery at academic teaching hospitals and impact on total length of hospital stay.

Authors:  Mary-Anne Aarts; Allan Okrainec; Amy Glicksman; Emily Pearsall; J Charles Victor; Robin S McLeod
Journal:  Surg Endosc       Date:  2011-10-20       Impact factor: 4.584

2.  Laparoscopic-assisted and open high anterior resection within an ERAS protocol.

Authors:  Ulf O Gustafsson; Marit Tiefenthal; Anders Thorell; Olle Ljungqvist; Jonas Nygrens
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

Review 3.  Enhanced recovery programme in colorectal surgery: does one size fit all?

Authors:  Alison Lyon; Christopher J Payne; Graham J Mackay
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

4.  The effect of enhanced recovery program for patients undergoing partial laparoscopic hepatectomy of liver cancer.

Authors:  F He; X Lin; F Xie; Y Huang; R Yuan
Journal:  Clin Transl Oncol       Date:  2015-05-22       Impact factor: 3.405

5.  Impact of an enhanced recovery program on short-term outcomes after scheduled laparoscopic colon resection.

Authors:  Nicoleta O Kolozsvari; Giovanni Capretti; Pepa Kaneva; Amy Neville; Franco Carli; Sender Liberman; Patrick Charlebois; Barry Stein; Melina C Vassiliou; Gerald M Fried; Liane S Feldman
Journal:  Surg Endosc       Date:  2012-07-19       Impact factor: 4.584

6.  Intraperitoneal wound in abdominal surgery.

Authors:  Arman Adam Kahokehr
Journal:  World J Crit Care Med       Date:  2013-02-04

7.  Enhanced recovery for colorectal surgery: Practical hints, results and future challenges.

Authors:  Gianpiero Gravante; Muhammad Elmussareh
Journal:  World J Gastrointest Surg       Date:  2012-08-27

8.  Fast track multi-discipline treatment (FTMDT trial) versus conventional treatment in colorectal cancer--the design of a prospective randomized controlled study.

Authors:  Jiao-Jiao Zhou; Jun Li; Xiao-Jiang Ying; Yong-Mao Song; Rong Chen; Gang Chen; Min Yan; Ke-Feng Ding
Journal:  BMC Cancer       Date:  2011-11-24       Impact factor: 4.430

9.  Why have we embraced minimally invasive surgery and ignored enhanced recovery after surgery?

Authors:  Aditya J Nanavati; Sanjay Nagral
Journal:  J Minim Access Surg       Date:  2016 Jul-Sep       Impact factor: 1.407

10.  Is ERAS in laparoscopic surgery for colorectal cancer changing risk factors for delayed recovery?

Authors:  Michał Pędziwiatr; Magdalena Pisarska; Michał Kisielewski; Maciej Matłok; Piotr Major; Mateusz Wierdak; Andrzej Budzyński; Olle Ljungqvist
Journal:  Med Oncol       Date:  2016-02-12       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.